effect liqurice in treatment of schizophernia
Phase 2
- Conditions
- schizophrenia.Schizophrenia
- Registration Number
- IRCT20111105008013N2
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Active schizophrenia
Met DSM-IV criteria for chronic schizophrenia
Drug regimen of risperidone (6 mg/day), cetirizine (4 mg/day)
Exclusion Criteria
Bipolar disorder
Borderline-schizotypal-Antisocial personality disorder
?Eating disorder
Alcohol and drug (other than schizophrenia drugs) abuse in the past month
Suicide or suicidal ideation
History of neurologic and systemic disorders
Thyroid dysfunction
Administration of antidepressants and Anti-anxiety drugs
Steroids (such as oral contraceptives)
Use of MAO-I drugs
Pregnancy and lactation
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive symptoms; Negative symptoms; General psychopathological symptoms. Timepoint: Start intervention and a month later. Method of measurement: PANSS score.
- Secondary Outcome Measures
Name Time Method